‘It is very personal’: AbCellera’s COVID-19 treatment is saving lives in the U.S. In Canada, it’s sitting in storage. Now the company’s CEO is speaking out

VANCOUVER — In early December, Kush Dalal answered a phone call from his 83-year-old father, then in a B.C. hospital battling COVID-19. Though coronavirus-related delirium had wreaked havoc in his brain, Dalal’s dad remembered his son was part of a team of scientists at local biotech company AbCellera who had developed a promising antibody therapy to counter the disease. He asked his son if the treatment was available for him. Dalal lied. “I had to tell him that the doctors have something better for [him] in the hospital,” he recalled. “I basically had to lie to him to calm him down, which was just heartbreaking.” Read More